Supplementary Table 1. CML patient characteristics
Abbreviations: N/A, not available; F, female; M, male; SE, Sweden; FI, Finland; NO, Norway; DK, Denmark; NL, Netherlands; Hb, hemoglobin; Leu, leukocytes; Trc, thrombocytes dg, diagnosis; 3mo, 3 months; 12mo, 12 months; RNA-Seq, RNA sequencing. *, antibody conjugated to biotin by Innovagen; **, CD3, CD14, CD16, CD19, CD20, CD56
Supplementary Figure Legends

Supplementary Figure S1
FACS gates used for sorting primary CML cells for in vitro cultures. The CD34 + CD38 low gate was set to include 5% of CD34 + cells. The IL1RAP gates were based on previously determined IL1RAP expression and set with approximately 10% margin. The CD36 positive and CD36 negative gates were based on previously determined CD36 expression for the particular CML sample leaving 20% of cells as CD36 intermediate in order
to obtain more pure cell populations. The figure shows CML #7 as a representative example. For CML #4 no IL1RAP-targeting antibody was used, instead CD36 gates were directly added to the CD34 + CD38 low cell fraction, the CD34 + CD38 low compartment of CML #4 were separately shown to be >90% IL1RAP + .
Supplementary Figure S2
RNA-sequencing of sorted primary CML CD34 + CD38 low cells from 10 newly diagnosed chronic phase CML patients and corresponding healthy controls (n=4). The heat map shows down regulated cell surface associated genes in primitive CML samples compared to healthy hematopoietic stem cell-enriced cells (up regulated genes are shown in Figure   1C )
Supplementary Figure S3
Low or absent expression of CD36 and LEPR in progenitor cells of healthy bone marrow. and LEPR expression in stem and progenitor populations from two normal bone marrow donors. Isotype based on all CD34 expressing cells. LMPP, lymphoid-primed multipotent progenitors (Lin -CD34 + CD38 -CD45RA + ); HSC, hematopoietic stem cells (Lin -CD34 + CD38 -CD90 + CD45RA -); MPP, multipotent progenitors (Lin -CD34 + CD38 -CD90 -CD45RA -); MEP, megakaryocyte-erythroid progenitors (Lin -CD34 + CD38 + CD123 -CD45RA -); GMP, granulocyte-macrophage progenitors (Lin -CD34 + CD38 + CD123 + CD45RA + ); CMP, common myeloid progenitors (Lin -CD34 + CD38 + CD123 + CD45RA -).
Supplementary Figure S4
The individual LEPR flow cytometry datapoints and their corresponding isotype control plotted in pairs show LEPR overexpression in CML samples (n=10) but not NBM (n=4).
Two asterisks (**) indicates p<0.01, ns; not significant. IGF1R  FLT3  IL11RA  ABCB1  DLK1  GPR126  PROM1  ANK3  TNFSF8  LRP6  TIMP2  ACVR2B  INSR  KIT  CLEC2D  CXCR7  CXCR4  PTGER2  PTGER4  CCR7  FGFRL1  EPHB4  SLC1A3 
Supplementary Figure S5
Name Subset Name Count NBM iso CD36 CD34+CD38+ 55500 NBM CD36 CD34+CD38+ 69934 Sample Name Subset Name Count MA iso CD36_002
